Table of Contents
Executive Summary — 6
SWOT
Analysis — 7
Argentina Pharmaceuticals And Healthcare
Industry SWOT — 7
Argentina Political
SWOT — 8
Argentina Economic SWOT — 9
Argentina Business Environment SWOT — 10
Pharmaceutical
Business Environment Ratings — 11
Table: Americas
Pharmaceutical Business Environment Rankings — 11
Limits
Of Potential Returns — 11
Risks To Realisation Of
Returns — 12
Argentina – Market
Summary — 14
Regulatory Regime — 16
OTC Regulation — 17
Recent Regulatory
Developments — 18
Intellectual Property (IP)
Environment — 19
IP Disputes — 21
Table: Joint Declaration By Latin American Health Ministers, May
2006 — 22
Counterfeit
Pharmaceuticals — 23
Pricing
Regime — 23
Table Argentina - Pharmaceutical Price
Build-Up — 23
Table: Argentina’s Drug Price Freeze,
2005-2008 — 25
Reimbursement
Regime — 26
Industry Trends And
Developments — 28
Epidemiology — 28
Healthcare Insurance — 31
Recent Healthcare Insurance
Developments — 31
Domestic Pharmaceutical
Sector — 32
Recent Developments in Domestic
Pharmaceuticals Sector — 34
Multinational Sector
Developments — 35
Vaccines Sector — 38
Recent Developments in the Vaccines Sector — 38
Pharmaceutical Wholesale Sector — 40
Medicinal
Plants — 43
Table Argentina - Imports of Medicinal Plants
by Country (US$’000) — 43
Research and Development
(R&D) — 44
Clinical Trials — 44
Medical Devices — 45
Industry Forecast
Scenario — 47
Overall Market
Forecast — 47
Table: Argentina - Drug Market Indicators,
Historical Data and Forecasts — 48
Key Growth Factors
– Industry — 49
Table: Argentina – Health
Expenditure Indicators, Historical Data and Forecasts — 50
Key Growth Factors – Macroeconomic — 51
Table:
Argentina – Economic Activity, 2006-2013 — 52
Prescription Market Forecast — 53
Table: Argentina -
Prescription Drug Market Indicators, Historical Data and Forecasts (US$mn
unless otherwise stated) — 54
Patented Market
Forecast — 55
Table: Argentina – Patented Market
Indicators, Historical Data and Forecasts — 56
Generics
Market Forecast — 57
Table: Argentina – Generics
Market Indicators , Historical Data and Forecasts — 58
OTC
Market Forecasts — 59
Table: Argentina – OTC**
Market Indicators, Historical Data and Forecasts (US$mn unless otherwise
stated) — 61
Pharmaceutical Trade
Forecasts — 62
Table Argentina – Imports of
Medicines Containing Vitamins by Country
(US$’000) — 63
Table: Argentina - Pharmaceutical
Trade Indicators, Historical Data and Forecasts
(US$mn) — 64
Other Healthcare Data
Forecasts — 65
Table: Argentina – Other Health
Indicators, Historical Data and Forecasts — 65
Key Risks
To BMI’s Forecast Scenario — 66
Competitive
Landscape — 67
Company Monitor — 68
Leading Foreign Companies — 68
Pfizer — 68
Roche — 69
Novartis — 71
GlaxoSmithKline
(GSK) — 72
Sanofi-Aventis — 74
Merck &
Co — 76
Boehringer Ingelheim — 78
Indigenous Manufacturers — 79
Laboratorios
Roemmers — 79
Laboratorios
Bagó — 81
Country Snapshot: Argentina Demographic
Data — 84
Section 1: Population — 84
Table: Demographic Indicators, 2005-2030 — 84
Table:
Rural/Urban Breakdown, 2005-2030 — 85
Section 2: Education
And Healthcare — 85
Table:
Education — 85
Table: Life Expectancy,
2005-2030 — 85
Section 3: Labour Market And Spending
Power — 86
Table: Employment Indicators,
2001-2006 — 86
Table: Consumer Expenditure, 2000-2012
(US$) — 86
Table: Average Annual Manufacturing Wages,
1995-2001 — 87
BMI Forecast
Modelling — 88
How We Generate Our Pharmaceutical Industry
Forecasts — 88
Pharmaceutical Business Environment Ratings
Methodology — 89
Ratings Overview — 89
Table: Pharmaceutical Business Environment Indicators — 90
Weighting — 91
Table: Weighting Of
Components — 91
Sources — 91
| 
View Cart
